Kate Hudson to represent Almay brand
NEW YORK —Revlon has tapped actress Kate Hudson to be the newest global brand ambassador for its Almay brand.
In her role for Almay, the Hollywood star will be the face of new and existing Almay products and will appear in global multimedia campaigns that include television, print, in-store and Web placements. Hudson’s first television and print campaign for the brand is set to debut later this year.
In addition to being featured in upcoming global advertising campaigns, Hudson will be involved in various company-sponsored philanthropic and fundraising events. For example, she represented the brand at the Almay Rain-forest Concert on May 13 at Carnegie Hall in New York. The concert benefited The Rainforest Foundation, founded by Sting and Trudie Styler to support indigenous and traditional people of the world’s rain forests in their efforts to protect their environment.
Hudson took Hollywood by storm in her Academy Award-nominated role of rock groupie Penny Lane in “Almost Famous” (2000), for which she won a Golden Globe Award. Her film credits include “How to Lose a Guy in 10 Days,” “Fool’s Gold,” “You, Me and Dupree” and “Bride Wars,” as well as most recently, Rob Marshall’s musical drama, “Nine.” She will next be seen on the big screen in Michael Winterbottom’s “The Killer Inside Me” with Casey Affleck and Jessica Alba and “Earthbound” with Kathy Bates and Whoopi Goldberg. She currently is filming the romantic comedy, “Something Borrowed.”
Mack Elevation Forum examines how NOT to become SKU-rationalized
SAN DIEGO It’s a new game. And the winners are the ones that follow the new rules of the game. That was how Swanson Group VP Dan Mack teed up the discussion here, Friday morning, at the Hilton Bayfront Hotel, for the latest edition of The Mack Elevation Forum.
The share group — which merged with the Swanson Group last November — organized and coordinated by Mack, brings together executives from noncompeting, generally smaller to mid-sized companies to examine critical business issues with the ultimate goal of enabling participants to align their sales and marketing strategies with the broader vision of the retailers they do business with. In all, executives from more than 20 different supplier companies were in attendance.
Among other things, the new rules, Mack explained, dictate that the pie of which suppliers fight to secure a share is smaller than it once was as retailers focus on growing their store brands; the new “value” consumer continues to grow in number — and value isn’t always defined by price; social media continues to level the playing field from a brand marketing standpoint, even as SKU rationalization does its best to shrink the playing field; and customer loyalty has reached an all-time low.
Special retailer guest, Bill Bergin, VP health and beauty for Rite Aid, provided attendees with an insider’s view of how suppliers can better engage Rite Aid, and shared details of key programs — such as the chain’s newly introduced Wellness+ customer loyalty card program, which the company began rolling out in May — that are priorities for Rite Aid.
Picking up on the theme of Drug Store News’ June 6 issue cover story, “7 Deadly Sins of SKU Rationalization,” Mack Elevation Forum attendees focused a good deal of the discussion around the topic of SKU rationalization — and, more importantly, how smaller vendors can keep out of the crosshairs.
To some extent, SKU rationalization has been a bit a of self-fulfilling prophesy, explained Vic Mazzacone, CEO of Drive Medical Design and Manufacturing, retail division. “The supplier community set the table for the radical SKU rationalization that is currently occurring,” he said, citing a lack of “real innovation. And overzealous marketers created a stream of new products that did not grow the segment and only traded sales. Too many brands are truly not differentiated, which makes them vulnerable.”
Dan Quail, VP sales for Similasan, noted that in one of his key business segments, the ear category, there historically have been six to seven other manufacturers competing within the section. “With some retailers, there are now only three manufacturers competing in the section,” Quail said. “It was a perfect case of companies not being differentiated and diluting the overall performance of the section.”
The bigger question, of course, is not so much what caused SKU rationalization, but what suppliers can do to keep from having their items eliminated. “Suppliers must understand emerging consumer trends and stay on the forefront of meeting evolving consumer needs,” said Mike Barna, VP sales for First Boston Pharma. “By staying out in front of the curve, you have the opportunity to create new products in growth segments where retailers are more willing to invest … and [you] are also more insulated against rationalization.”
Audie Rudiger, VP sales for Wahl, noted that the 80-year-old clipper company utilizes data from Zoomerang to identify consumer preferences, and uses that information to help support why its products must be a part of the planogram. Rudiger also recommended the online consumer survey service Questback.com for deeper qualitative and quantitative consumer feedback, and QuestionPro for more complex consumer research.
Another strategy for maintaining an item’s place on the shelf is to demonstrate that item’s contribution to the overall market basket, or the value of the trip the item generates, or that the value of that shopper is higher than the category norm, noted Tina Jackse, senior director of national accounts for Beiersdorf. “Try to establish if your brand — if not on the shelf — encouraged the consumer to leave the store.”
In the end, it is important for suppliers to leverage all of their assets to bring constant value back to the retailer. “Winning companies are bringing products to their retailer partners, but they also provide context on national best practices and are students of the important societal shifts,” Mack explained. “They understand that the game is about bringing ideas that help retailers build customer loyalty, drive trips and encourage in-store conversion. Companies offering these type of assets build strong brands and are more immune to being delisted.”
La Roche-Posay to launch Redermic[+]
NEW YORK La Roche-Posay is launching in July at select CVS stores, CVS.com and select Duane Reade locations its new anti-aging formula called Redermic[+], which stems from research into sensitive skin.
According to the manufacturer, it is the first wrinkle-filling treatment to combat the micro-inflammatory source of aging. Redermic [+] contains three corrective anti-aging ingredients: 5% pure vitamin C, essential in the fight against aging:
- Reinforces cutaneous support
- The dermatological reference ingredient to boost the synthesis of support fibers [collagen IV and VII]
- Vitamin C demonstrates optimum efficacy on collagen and wrinkles when concentrated at 5%
Madecassoside, a “custaneous repairer”:
- Fills in deep wrinkles
- Regenerative action of dermal fibers via stimulation of collagen I and III synthesis
- Stemming from skin healing research, Madecassoside helps to restructure the dermal extra-cellular matrix
Hyaluronic acid, “instant smoothing” effect:
- Smoothes surface wrinkles
- Restores optimal hydration levels to smooth wrinkles
- Following surface application, water is captured and locked in, helping to smooth fine lines on skin’s surface.
There is Redermic [+] for normal to combination skin and dry skin ($48). There’s also an eye treatment ($38).